---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-241970"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2022-09-09T23:59:59+00:00"
generated_at: "2026-06-23T12:14:27.604657+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics restructures Novartis license milestone payments, issues ~$7M in stock

## Summary
- Amended license with Novartis for MAU868; capped total milestone payments at $62.0M.
- Issuing 283,034 shares of Class A common stock to Novartis, valued at ~$7M based on closing price plus 20% premium.
- Share issuance expected to close on or about September 13, 2022.
- Modification adjusts development and regulatory milestone payment structure under the existing license.

## SEC filing metadata
- accession: 0001193125-22-241970
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2022-09-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312522241970/0001193125-22-241970-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312522241970/d265248d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-241970
- JSON: https://secwatch.observer/filing/0001193125-22-241970.json
- Plain text: https://secwatch.observer/filing/0001193125-22-241970.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.